product summary
company name :
Hycult Biotech
product type :
antibody
product name :
JAM-A, Human, mAb BV16, FITC
catalog :
HM2098F
quantity :
100 µg
clonality :
monoclonal
host :
mouse
conjugate :
FITC
clone name :
BV16
reactivity :
human
application :
western blot, immunocytochemistry, flow cytometry, immunohistochemistry - frozen section
more info or order :
citations: 2
Reference
Koenen R, Pruessmeyer J, Soehnlein O, Fraemohs L, Zernecke A, Schwarz N, et al. Regulated release and functional modulation of junctional adhesion molecule A by disintegrin metalloproteinases. Blood. 2009;113:4799-809 pubmed publisher
Gutwein P, Schramme A, Voss B, Abdel Bakky M, Doberstein K, Ludwig A, et al. Downregulation of junctional adhesion molecule-A is involved in the progression of clear cell renal cell carcinoma. Biochem Biophys Res Commun. 2009;380:387-91 pubmed publisher
product information
Catalog no :
HM2098F
Title :
JAM-A, Human, mAb BV16, FITC
Clone no :
BV16
Quantity :
100 µg
Origin :
Fusion protein consisting of the extracellular domain of JAM and the Fc portion of humans IgGs
Application code :
frozen sections,flow cytometry,western blot,immunofluorescence
Species :
Human
Host species :
Mouse
Isotype :
IgG1
Conjugate :
FITC
Aliases :
PAM-1, JAM-1, JAMA, CD321, Platelet F11 receptor, Juntional adhesion molecule
Type :
mAb
Antigen :
JAM-A
Meta data :
PAM-1, JAM-1, JAMA, CD321, Platelet F11 receptor, Juntional adhesion molecule
more info or order :
company information
Hycult Biotech
Frontstraat 2a
5405 PB UDEN
support@hycultbiotech.com
www.hycultbiotech.com
31 0 413 25 13 35
headquarters: Netherlands
Hycult Biotech develops, produces and markets antibodies, antibody based products and more specifically immunoassays for innate immunity and directly related fields, with an emphasis on complement, neutrophil proteins, TLR, scavenger receptors and acute phase proteins. Furthermore, we have a strong interest in progressing research in the area of inflammation and cell damage caused by pathogens or oxidation factors.

Hycult Biotech’s mission and strategy is to advance insight in innate immunity related diseases, for the benefit of individuals and their quality of life.

As a leader within focused fields of immunology and cell biology, we develop products for the life sciences and in accordance with our mission it is our ambition to facilitate the transition of these products from research use into diagnostic testing. Many of our reagents are developed in close cooperation with scientists worldwide. Hycult Biotech has built a strong network with over 40 close scientific collaborations with leading international research institutes. We contribute to numerous projects and as a result, can continuously offer early access to an expanding range of innovative reagents. Hycult Biotech has been ISO-9001 certified since 1998 and we upgraded our certification to ISO-13485 in 2007, with a milestone of our first release of CE marked assays in 2009. Our vision, knowledgeable team and quality management system guarantee products of the highest grade combined with excellent technical service.